Press Releases

The Foundation for the National Institutes of Health (FNIH) and the Cancer Research Institute (CRI) announced today that FNIH has selected CRI to be its source of landscape intelligence in immuno-oncology, also called cancer immunotherapy. 

The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has elected world-renowned scientific leader Marijn Dekkers, Ph.D., Chairman of Unilever, as its newest member. Dr. Dekkers’ appointment took effect on May 17, 2018.

 

Prize bestowed to Dr. Zhijian “James” Chen for discovery of the cGAS enzyme and its DNA-sensing pathway and their impact on immune defense and autoimmune disease.

The Foundation for the National Institutes of Health (FNIH) is pleased to open nominations for the inaugural Trailblazer Prize for Clinician-Scientists (Trailblazer Prize). This annual prize and $10,000 honorarium presented by the FNIH recognizes the outstanding contributions of early career clinician-scientists in the United States whose work has the potential to or has led to innovations in patient care. To nominate a colleague for this prize and learn about eligibility criteria, visit fnih.org/TrailblazerPrize. Nominations will be accepted through Friday, March 30 at 1:00 p.m. ET.

The Foundation for the National Institutes of Health (FNIH) is proud to announce that it received the Gold Stevie Award for Organization of the Year in the government/nonprofit category of the Women in Business Awards. The FNIH’s President and Executive Director, Maria C. Freire, Ph.D., also received a Gold Stevie Award for Woman of the Year in the government/non-profit category. 

The Foundation for the National Institutes of Health (FNIH) is proud to announce that President and Executive Director Maria C. Freire, Ph.D. has won a Washington Business Journal Women Who Mean Business Award. Now in its 14th year, this prestigious award honors the Washington, D.C. metropolitan area’s most influential business women across every industry and profession.

The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Fred Seigel as a new member. Mr. Seigel is President and Chief Operating Officer of Beacon Capital Partners, a private real estate investment company based in Boston.

The Foundation for the National Institutes of Health (FNIH) has selected David M. Sabatini, M.D., Ph.D., to receive its fifth annual Lurie Prize in Biomedical Sciences for discovery of the mTOR (mechanistic target of rapamycin) cellular pathway as a key regulator of growth and metabolism in response to nutrients. Dr. Sabatini is a pioneer in the study of nutrient sensing and the impact of caloric restriction on health and lifespan. The Lurie Prize in Biomedical Sciences will be presented to Dr. Sabatini at the FNIH Award Ceremony hosted by CNN’s Wolf Blitzer on May 17 in Washington, D.C.

Driven to Cure, Inc., a not-for-profit dedicated to raising awareness and funding rare kidney cancer research in children and young adults, has donated $200,000 to the Foundation for the National Institutes of Health (FNIH). The donation will support the research of W. Marston Linehan, M.D., Chief of Urologic Surgery and the Urologic Oncology Branch, Center for Cancer Research, at the National Cancer Institute (NCI), who is developing novel approaches to treat multiple forms of kidney cancer.

FNIH on Twitter